Global Plasma Fractionation and Blood Product Market Research Report 2025(Status and Outlook)

March 2025 | 222 pages | ID: GCF9170B52F1EN
Bosson Research

Abstracts

Report Overview

Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called Plasma Fractionation.

This report provides a deep insight into the global Plasma Fractionation and Blood Product market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Plasma Fractionation and Blood Product Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Plasma Fractionation and Blood Product market in any manner.

Global Plasma Fractionation and Blood Product Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Takeda

CSL

Grifols

Octapharma

Kedrion

LFB Group

Biotest

BPL

RAAS

CBPO

Hualan Bio

Market Segmentation (by Type)

Coagulation Factor

Immune Globulin

Albumin

Other

Market Segmentation (by Application)

Immunology

Hematology

Other

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Plasma Fractionation and Blood Product Market
• Overview of the regional outlook of the Plasma Fractionation and Blood Product Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Plasma Fractionation and Blood Product Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Plasma Fractionation and Blood Product
1.2 Key Market Segments
1.2.1 Plasma Fractionation and Blood Product Segment by Type
1.2.2 Plasma Fractionation and Blood Product Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Global Plasma Fractionation and Blood Product Market Overview
2.1 Global Market Overview
2.1.1 Global Plasma Fractionation and Blood Product Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Plasma Fractionation and Blood Product Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Global Plasma Fractionation and Blood Product Market Competitive Landscape
3.1 Company Assessment Quadrant
3.2 Global Plasma Fractionation and Blood Product Product Life Cycle
3.3 Global Plasma Fractionation and Blood Product Sales by Manufacturers (2020-2025)
3.4 Global Plasma Fractionation and Blood Product Revenue Market Share by Manufacturers (2020-2025)
3.5 Plasma Fractionation and Blood Product Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Plasma Fractionation and Blood Product Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Plasma Fractionation and Blood Product Manufacturing Sites, Area Served, Product Type
3.8 Plasma Fractionation and Blood Product Market Competitive Situation and Trends
3.8.1 Plasma Fractionation and Blood Product Market Concentration Rate
3.8.2 Global 5 and 10 Largest Plasma Fractionation and Blood Product Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 Plasma Fractionation and Blood Product Industry Chain Analysis
4.1 Plasma Fractionation and Blood Product Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Plasma Fractionation and Blood Product Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Plasma Fractionation and Blood Product Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 Global Trade Frictions and Their Impacts to Plasma Fractionation and Blood Product Market
5.7 ESG Ratings of Leading Companies
6 Global Plasma Fractionation and Blood Product Market by Region
6.1 Global Plasma Fractionation and Blood Product Market Size by Region
6.1.1 Global Plasma Fractionation and Blood Product Market Size by Region
6.1.2 Global Plasma Fractionation and Blood Product Market Size Market Share by Region
6.2 Global Plasma Fractionation and Blood Product Sales by Region
6.2.1 Global Plasma Fractionation and Blood Product Sales by Region
6.2.2 Global Plasma Fractionation and Blood Product Sales Market Share by Region
7 North America Market Overview
7.1 North America Plasma Fractionation and Blood Product Market Size by Country
7.1.1 USA Market Overview
7.1.2 Canada Market Overview
7.1.3 Mexico Market Overview
7.2 North America Plasma Fractionation and Blood Product Market Size by Type
7.3 North America Plasma Fractionation and Blood Product Market Size by Application
8 Europe Market Overview
8.1 Europe Plasma Fractionation and Blood Product Market Size by Country
8.1.1 Germany Market Overview
8.1.2 France Market Overview
8.1.3 U.K. Market Overview
8.1.4 Italy Market Overview
8.1.5 Spain Market Overview
8.2 Europe Plasma Fractionation and Blood Product Market Size by Type
8.3 Europe Plasma Fractionation and Blood Product Market Size by Application
9 Asia-Pacific Market Overview
9.1 Asia-Pacific Plasma Fractionation and Blood Product Market Size by Country
9.1.1 China Market Overview
9.1.2 Japan Market Overview
9.1.3 South Korea Market Overview
9.1.4 India Market Overview
9.1.5 Southeast Asia Market Overview
9.2 Asia-Pacific Plasma Fractionation and Blood Product Market Size by Type
9.3 Asia-Pacific Plasma Fractionation and Blood Product Market Size by Application
10 South America Market Overview
10.1 South America Plasma Fractionation and Blood Product Market Size by Country
10.1.1 Brazil Market Overview
10.1.2 Argentina Market Overview
10.1.3 Columbia Market Overview
10.2 South America Plasma Fractionation and Blood Product Market Size by Type
10.3 South America Plasma Fractionation and Blood Product Market Size by Application
11 Middle East and Africa Market Overview
11.1 Middle East and Africa Plasma Fractionation and Blood Product Market Size by Country
11.1.1 Saudi Arabia Market Overview
11.1.2 UAE Market Overview
11.1.3 Egypt Market Overview
11.1.4 Nigeria Market Overview
11.1.5 South Africa Market Overview
11.2 Middle East and Africa Plasma Fractionation and Blood Product Market Size by Type
11.3 Middle East and Africa Plasma Fractionation and Blood Product Market Size by Application
12 Plasma Fractionation and Blood Product Market Production by Region
12.1 Global Production of Plasma Fractionation and Blood Product by Region(2020-2025)
12.2 Global Plasma Fractionation and Blood Product Revenue Market Share by Region (2020-2025)
12.3 Global Plasma Fractionation and Blood Product Production, Revenue, Price and Gross Margin (2020-2025)
12.4 North America Plasma Fractionation and Blood Product Production
12.4.1 North America Plasma Fractionation and Blood Product Production Growth Rate (2020-2025)
12.4.2 North America Plasma Fractionation and Blood Product Production, Revenue, Price and Gross Margin (2020-2025)
12.5 Europe Plasma Fractionation and Blood Product Production
12.5.1 Europe Plasma Fractionation and Blood Product Production Growth Rate (2020-2025)
12.5.2 Europe Plasma Fractionation and Blood Product Production, Revenue, Price and Gross Margin (2020-2025)
12.6 Japan Plasma Fractionation and Blood Product Production (2020-2025)
12.6.1 Japan Plasma Fractionation and Blood Product Production Growth Rate (2020-2025)
12.6.2 Japan Plasma Fractionation and Blood Product Production, Revenue, Price and Gross Margin (2020-2025)
12.7 China Plasma Fractionation and Blood Product Production (2020-2025)
12.7.1 China Plasma Fractionation and Blood Product Production Growth Rate (2020-2025)
12.7.2 China Plasma Fractionation and Blood Product Production, Revenue, Price and Gross Margin (2020-2025)
13 Plasma Fractionation and Blood Product Market Segmentation by Type
13.1 Evaluation Matrix of Segment Market Development Potential (Type)
13.2 Global Plasma Fractionation and Blood Product Sales Market Share by Type (2020-2033)
13.3 Global Plasma Fractionation and Blood Product Market Size Market Share by Type (2020-2033)
13.4 Global Plasma Fractionation and Blood Product Price by Type (2020-2033)
14 Plasma Fractionation and Blood Product Market Segmentation by Application
14.1 Evaluation Matrix of Segment Market Development Potential (Application)
14.2 Global Plasma Fractionation and Blood Product Market Sales by Application (2020-2033)
14.3 Global Plasma Fractionation and Blood Product Market Size (M USD) by Application (2020-2033)
14.4 Global Plasma Fractionation and Blood Product Sales Growth Rate by Application (2020-2033)
15 Key Companies Profile
15.1 Takeda
15.1.1 Takeda Basic Information
15.1.2 Takeda Plasma Fractionation and Blood Product Product Overview
15.1.3 Takeda Plasma Fractionation and Blood Product Product Market Performance
15.1.4 Takeda Business Overview
15.1.5 Takeda SWOT Analysis
15.1.6 Takeda Recent Developments
15.2 CSL
15.2.1 CSL Basic Information
15.2.2 CSL Plasma Fractionation and Blood Product Product Overview
15.2.3 CSL Plasma Fractionation and Blood Product Product Market Performance
15.2.4 CSL Business Overview
15.2.5 CSL SWOT Analysis
15.2.6 CSL Recent Developments
15.3 Grifols
15.3.1 Grifols Basic Information
15.3.2 Grifols Plasma Fractionation and Blood Product Product Overview
15.3.3 Grifols Plasma Fractionation and Blood Product Product Market Performance
15.3.4 Grifols Business Overview
15.3.5 Grifols SWOT Analysis
15.3.6 Grifols Recent Developments
15.4 Octapharma
15.4.1 Octapharma Basic Information
15.4.2 Octapharma Plasma Fractionation and Blood Product Product Overview
15.4.3 Octapharma Plasma Fractionation and Blood Product Product Market Performance
15.4.4 Octapharma Business Overview
15.4.5 Octapharma Recent Developments
15.5 Kedrion
15.5.1 Kedrion Basic Information
15.5.2 Kedrion Plasma Fractionation and Blood Product Product Overview
15.5.3 Kedrion Plasma Fractionation and Blood Product Product Market Performance
15.5.4 Kedrion Business Overview
15.5.5 Kedrion Recent Developments
15.6 LFB Group
15.6.1 LFB Group Basic Information
15.6.2 LFB Group Plasma Fractionation and Blood Product Product Overview
15.6.3 LFB Group Plasma Fractionation and Blood Product Product Market Performance
15.6.4 LFB Group Business Overview
15.6.5 LFB Group Recent Developments
15.7 Biotest
15.7.1 Biotest Basic Information
15.7.2 Biotest Plasma Fractionation and Blood Product Product Overview
15.7.3 Biotest Plasma Fractionation and Blood Product Product Market Performance
15.7.4 Biotest Business Overview
15.7.5 Biotest Recent Developments
15.8 BPL
15.8.1 BPL Basic Information
15.8.2 BPL Plasma Fractionation and Blood Product Product Overview
15.8.3 BPL Plasma Fractionation and Blood Product Product Market Performance
15.8.4 BPL Business Overview
15.8.5 BPL Recent Developments
15.9 RAAS
15.9.1 RAAS Basic Information
15.9.2 RAAS Plasma Fractionation and Blood Product Product Overview
15.9.3 RAAS Plasma Fractionation and Blood Product Product Market Performance
15.9.4 RAAS Business Overview
15.9.5 RAAS Recent Developments
15.10 CBPO
15.10.1 CBPO Basic Information
15.10.2 CBPO Plasma Fractionation and Blood Product Product Overview
15.10.3 CBPO Plasma Fractionation and Blood Product Product Market Performance
15.10.4 CBPO Business Overview
15.10.5 CBPO Recent Developments
15.11 Hualan Bio
15.11.1 Hualan Bio Basic Information
15.11.2 Hualan Bio Plasma Fractionation and Blood Product Product Overview
15.11.3 Hualan Bio Plasma Fractionation and Blood Product Product Market Performance
15.11.4 Hualan Bio Business Overview
15.11.5 Hualan Bio Recent Developments
16 Conclusion and Key FindingsList of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Plasma Fractionation and Blood Product Market Size by Type (M USD)
Table 4. Global Plasma Fractionation and Blood Product Market Size by Application (M USD)
Table 5. Plasma Fractionation and Blood Product Market Size Comparison by Region (M USD)
Table 6. Global Plasma Fractionation and Blood Product Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Plasma Fractionation and Blood Product Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Plasma Fractionation and Blood Product Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Plasma Fractionation and Blood Product Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasma Fractionation and Blood Product as of 2024)
Table 11. Global Market Plasma Fractionation and Blood Product Average Price (USD/MT) of Key Manufacturers (2020-2025)
Table 12. Manufacturers Plasma Fractionation and Blood Product Manufacturing Sites and Area Served
Table 13. Manufacturers Plasma Fractionation and Blood Product Product Type
Table 14. Global Plasma Fractionation and Blood Product Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Plasma Fractionation and Blood Product Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 25. Plasma Fractionation and Blood Product Market Size Comparison by Region (M USD)
Table 26. Global Plasma Fractionation and Blood Product Market Size by Region (2020-2033) & (M USD)
Table 27. Global Plasma Fractionation and Blood Product Market Size Market Share by Region (2020-2033)
Table 28. Global Plasma Fractionation and Blood Product Sales by Region (2020-2033) & (K MT)
Table 29. Global Plasma Fractionation and Blood Product Sales Market Share by Region (2020-2033)
Table 30. North America Plasma Fractionation and Blood Product Market Size by Country (2020-2033) & (M USD)
Table 31. North America Plasma Fractionation and Blood Product Sales by Country (2020-2033) & (K MT)
Table 32. North America Plasma Fractionation and Blood Product Sales by Type (K MT)
Table 33. North America Plasma Fractionation and Blood Product Market Size by Type (M USD)
Table 34. North America Plasma Fractionation and Blood Product Sales (K MT) by Type (2020-2033)
Table 35. North America Plasma Fractionation and Blood Product Market Size (M USD) by Type (2020-2033)
Table 36. North America Plasma Fractionation and Blood Product Sales by Application (K MT)
Table 37. North America Plasma Fractionation and Blood Product Market Size by Application (M USD)
Table 38. North America Plasma Fractionation and Blood Product Sales (K MT) by Application (2020-2033)
Table 39. North America Plasma Fractionation and Blood Product Market Size (M USD) by Application (2020-2033)
Table 40. Europe Plasma Fractionation and Blood Product Market Size by Country (2020-2033) & (M USD)
Table 41. Europe Plasma Fractionation and Blood Product Sales by Country (2020-2033) & (K MT)
Table 42. Europe Plasma Fractionation and Blood Product Sales by Type (K MT)
Table 43. Europe Plasma Fractionation and Blood Product Market Size by Type (M USD)
Table 44. Europe Plasma Fractionation and Blood Product Sales (K MT) by Type (2020-2033)
Table 45. Europe Plasma Fractionation and Blood Product Market Size (M USD) by Type (2020-2033)
Table 46. Europe Plasma Fractionation and Blood Product Sales by Application (K MT)
Table 47. Europe Plasma Fractionation and Blood Product Market Size by Application (M USD)
Table 48. Europe Plasma Fractionation and Blood Product Sales (K MT) by Application (2020-2033)
Table 49. Europe Plasma Fractionation and Blood Product Market Size (M USD) by Application (2020-2033)
Table 50. Asia-Pacific Plasma Fractionation and Blood Product Market Size by Country (2020-2025) & (M USD)
Table 51. Asia-Pacific Plasma Fractionation and Blood Product Sales by Country (2020-2025) & (K MT)
Table 52. Asia-Pacific Plasma Fractionation and Blood Product Sales by Type (K MT)
Table 53. Asia-Pacific Plasma Fractionation and Blood Product Market Size by Type (M USD)
Table 54. Asia-Pacific Plasma Fractionation and Blood Product Sales (K MT) by Type (2020-2033)
Table 55. Asia-Pacific Plasma Fractionation and Blood Product Market Size (M USD) by Type (2020-2025)
Table 56. Asia-Pacific Plasma Fractionation and Blood Product Sales by Application (K MT)
Table 57. Asia-Pacific Plasma Fractionation and Blood Product Market Size by Application (M USD)
Table 58. Asia-Pacific Plasma Fractionation and Blood Product Sales (K MT) by Application (2020-2033)
Table 59. Asia-Pacific Plasma Fractionation and Blood Product Market Size (M USD) by Application (2020-2025)
Table 60. South America Plasma Fractionation and Blood Product Market Size by Country (2020-2033) & (M USD)
Table 61. South America Plasma Fractionation and Blood Product Sales by Country (2020-2033) & (K MT)
Table 62. South America Plasma Fractionation and Blood Product Sales by Type (K MT)
Table 63. South America Plasma Fractionation and Blood Product Market Size by Type (M USD)
Table 64. South America Plasma Fractionation and Blood Product Sales (K MT) by Type (2020-2033)
Table 65. South America Plasma Fractionation and Blood Product Market Size (M USD) by Type (2020-2033)
Table 66. South America Plasma Fractionation and Blood Product Sales by Application (K MT)
Table 67. South America Plasma Fractionation and Blood Product Market Size by Application (M USD)
Table 68. South America Plasma Fractionation and Blood Product Sales (K MT) by Application (2020-2033)
Table 69. South America Plasma Fractionation and Blood Product Market Size (M USD) by Application (2020-2033)
Table 70. Middle East and Africa Plasma Fractionation and Blood Product Market Size by Country (2020-2033) & (M USD)
Table 71. Middle East and Africa Plasma Fractionation and Blood Product Sales by Country (2020-2033) & (K MT)
Table 72. Middle East and Africa Plasma Fractionation and Blood Product Sales by Type (K MT)
Table 73. Middle East and Africa Plasma Fractionation and Blood Product Market Size by Type (M USD)
Table 74. Middle East and Africa Plasma Fractionation and Blood Product Sales (K MT) by Type (2020-2033)
Table 75. Middle East and Africa Plasma Fractionation and Blood Product Market Size (M USD) by Type (2020-2033)
Table 76. Middle East and Africa Plasma Fractionation and Blood Product Sales by Application (K MT)
Table 77. Middle East and Africa Plasma Fractionation and Blood Product Market Size by Application (M USD)
Table 78. Middle East and Africa Plasma Fractionation and Blood Product Sales (K MT) by Application (2020-2033)
Table 79. Middle East and Africa Plasma Fractionation and Blood Product Market Size (M USD) by Application (2020-2033)
Table 80. Global Plasma Fractionation and Blood Product Production (K MT) by Region(2020-2025)
Table 81. Global Plasma Fractionation and Blood Product Revenue (US$ Million) by Region (2020-2025)
Table 82. Global Plasma Fractionation and Blood Product Revenue Market Share by Region (2020-2025)
Table 83. Global Plasma Fractionation and Blood Product Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 84. North America Plasma Fractionation and Blood Product Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 85. Europe Plasma Fractionation and Blood Product Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 86. Japan Plasma Fractionation and Blood Product Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 87. China Plasma Fractionation and Blood Product Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 88. Global Plasma Fractionation and Blood Product Sales by Type (K MT)
Table 89. Global Plasma Fractionation and Blood Product Market Size by Type (M USD)
Table 90. Global Plasma Fractionation and Blood Product Sales (K MT) by Type (2020-2033)
Table 91. Global Plasma Fractionation and Blood Product Sales Market Share by Type (2020-2033)
Table 92. Global Plasma Fractionation and Blood Product Market Size (M USD) by Type (2020-2033)
Table 93. Global Plasma Fractionation and Blood Product Market Size Share by Type (2020-2033)
Table 94. Global Plasma Fractionation and Blood Product Sales (K MT) by Application
Table 95. Global Plasma Fractionation and Blood Product Market Size by Application(M USD)
Table 96. Global Plasma Fractionation and Blood Product Sales by Application (2020-2033) & (K MT)
Table 97. Global Plasma Fractionation and Blood Product Sales Market Share by Application (2020-2033)
Table 98. Global Plasma Fractionation and Blood Product Market Size by Application (2020-2033) & (M USD)
Table 99. Global Plasma Fractionation and Blood Product Market Share by Application (2020-2033)
Table 100. Global Plasma Fractionation and Blood Product Sales Growth Rate by Application (2020-2033)
Table 101. Takeda Basic Information
Table 102. Takeda Plasma Fractionation and Blood Product Product Overview
Table 103. Takeda Plasma Fractionation and Blood Product Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 104. Takeda Business Overview
Table 105. Takeda SWOT Analysis
Table 106. Takeda Recent Developments
Table 107. CSL Basic Information
Table 108. CSL Plasma Fractionation and Blood Product Product Overview
Table 109. CSL Plasma Fractionation and Blood Product Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 110. CSL Business Overview
Table 111. CSL SWOT Analysis
Table 112. CSL Recent Developments
Table 113. Grifols Basic Information
Table 114. Grifols Plasma Fractionation and Blood Product Product Overview
Table 115. Grifols Plasma Fractionation and Blood Product Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 116. Grifols Business Overview
Table 117. Grifols SWOT Analysis
Table 118. Grifols Recent Developments
Table 119. Octapharma Basic Information
Table 120. Octapharma Plasma Fractionation and Blood Product Product Overview
Table 121. Octapharma Plasma Fractionation and Blood Product Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 122. Octapharma Business Overview
Table 123. Octapharma Recent Developments
Table 124. Kedrion Basic Information
Table 125. Kedrion Plasma Fractionation and Blood Product Product Overview
Table 126. Kedrion Plasma Fractionation and Blood Product Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 127. Kedrion Business Overview
Table 128. Kedrion Recent Developments
Table 129. LFB Group Basic Information
Table 130. LFB Group Plasma Fractionation and Blood Product Product Overview
Table 131. LFB Group Plasma Fractionation and Blood Product Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 132. LFB Group Business Overview
Table 133. LFB Group Recent Developments
Table 134. Biotest Basic Information
Table 135. Biotest Plasma Fractionation and Blood Product Product Overview
Table 136. Biotest Plasma Fractionation and Blood Product Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 137. Biotest Business Overview
Table 138. Biotest Recent Developments
Table 139. BPL Basic Information
Table 140. BPL Plasma Fractionation and Blood Product Product Overview
Table 141. BPL Plasma Fractionation and Blood Product Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 142. BPL Business Overview
Table 143. BPL Recent Developments
Table 144. RAAS Basic Information
Table 145. RAAS Plasma Fractionation and Blood Product Product Overview
Table 146. RAAS Plasma Fractionation and Blood Product Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 147. RAAS Business Overview
Table 148. RAAS Recent Developments
Table 149. CBPO Basic Information
Table 150. CBPO Plasma Fractionation and Blood Product Product Overview
Table 151. CBPO Plasma Fractionation and Blood Product Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 152. CBPO Business Overview
Table 153. CBPO Recent Developments
Table 154. Hualan Bio Basic Information
Table 155. Hualan Bio Plasma Fractionation and Blood Product Product Overview
Table 156. Hualan Bio Plasma Fractionation and Blood Product Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2020-2025)
Table 157. Hualan Bio Business Overview
Table 158. Hualan Bio Recent Developments
List of Figures
Figure 1. Product Picture of Plasma Fractionation and Blood Product
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Plasma Fractionation and Blood Product Market Size (M USD), 2024-2033
Figure 5. Global Plasma Fractionation and Blood Product Market Size (M USD) (2020-2033)
Figure 6. Global Plasma Fractionation and Blood Product Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Plasma Fractionation and Blood Product Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Plasma Fractionation and Blood Product Product Life Cycle
Figure 13. Plasma Fractionation and Blood Product Sales Share by Manufacturers in 2024
Figure 14. Global Plasma Fractionation and Blood Product Revenue Share by Manufacturers in 2024
Figure 15. Plasma Fractionation and Blood Product Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Plasma Fractionation and Blood Product Average Price (USD/MT) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Plasma Fractionation and Blood Product Revenue in 2024
Figure 18. Industry Chain Map of Plasma Fractionation and Blood Product
Figure 19. Global Plasma Fractionation and Blood Product Market PEST Analysis
Figure 20. Global Plasma Fractionation and Blood Product Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Regional Market Development Potential
Figure 26. Global Plasma Fractionation and Blood Product Market Size by Region
Figure 27. Global Plasma Fractionation and Blood Product Market Size Market Share by Region (2020-2033)
Figure 28. Global Plasma Fractionation and Blood Product Sales Market Share by Region (2020-2033)
Figure 29. North American Market Snapshot
Figure 30. North America Plasma Fractionation and Blood Product Sales and Growth Rate (2020-2033) & (K MT)
Figure 31. North America Plasma Fractionation and Blood Product Market Size and Growth Rate (2020-2033) & (M USD)
Figure 32. North America Plasma Fractionation and Blood Product Market Size (M USD) by Country
Figure 33. USA Plasma Fractionation and Blood Product Sales and Growth Rate (2020-2033) & (K MT)
Figure 34. USA Plasma Fractionation and Blood Product Market Size and Growth Rate (2020-2033) & (M USD)
Figure 35. Canada Plasma Fractionation and Blood Product Sales (K MT) and Growth Rate (2020-2033)
Figure 36. Canada Plasma Fractionation and Blood Product Market Size (M USD) and Growth Rate (2020-2033)
Figure 37. Mexico Plasma Fractionation and Blood Product Sales (Units) and Growth Rate (2020-2033)
Figure 38. Mexico Plasma Fractionation and Blood Product Market Size (M USD) and Growth Rate (2020-2033)
Figure 39. North America Plasma Fractionation and Blood Product Market Size (M USD)by Type
Figure 40. North America Plasma Fractionation and Blood Product Market Size (M USD) by Application
Figure 41. Europe Market Snapshot
Figure 42. Europe Plasma Fractionation and Blood Product Sales and Growth Rate (2020-2033) & (K MT)
Figure 43. Europe Plasma Fractionation and Blood Product Market Size and Growth Rate (2020-2033) & (M USD)
Figure 44. Europe Plasma Fractionation and Blood Product Market Size (M USD) by Country
Figure 45. Germany Plasma Fractionation and Blood Product Sales and Growth Rate (2020-2033) & (K MT)
Figure 46. Germany Plasma Fractionation and Blood Product Market Size and Growth Rate (2020-2033) & (M USD)
Figure 47. France Plasma Fractionation and Blood Product Sales and Growth Rate (2020-2033) & (K MT)
Figure 48. France Plasma Fractionation and Blood Product Market Size and Growth Rate (2020-2033) & (M USD)
Figure 49. U.K. Plasma Fractionation and Blood Product Sales and Growth Rate (2020-2033) & (K MT)
Figure 50. U.K. Plasma Fractionation and Blood Product Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Italy Plasma Fractionation and Blood Product Sales and Growth Rate (2020-2033) & (K MT)
Figure 52. Italy Plasma Fractionation and Blood Product Market Size and Growth Rate (2020-2033) & (M USD)
Figure 53. Spain Plasma Fractionation and Blood Product Sales and Growth Rate (2020-2033) & (K MT)
Figure 54. Spain Plasma Fractionation and Blood Product Market Size and Growth Rate (2020-2033) & (M USD)
Figure 55. Europe Plasma Fractionation and Blood Product Market Size (M USD) by Type
Figure 56. Europe Plasma Fractionation and Blood Product Market Size (M USD) by Application
Figure 57. Asia-Pacific Market Snapshot
Figure 58. Asia-Pacific Plasma Fractionation and Blood Product Sales and Growth Rate (2020-2033) & (K MT)
Figure 59. Asia-Pacific Plasma Fractionation and Blood Product Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Asia-Pacific Plasma Fractionation and Blood Product Market Size (M USD) by Country
Figure 61. China Plasma Fractionation and Blood Product Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. China Plasma Fractionation and Blood Product Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Japan Plasma Fractionation and Blood Product Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Japan Plasma Fractionation and Blood Product Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. South Korea Plasma Fractionation and Blood Product Sales and Growth Rate (2020-2025) & (K MT)
Figure 66. South Korea Plasma Fractionation and Blood Product Market Size and Growth Rate (2020-2025) & (M USD)
Figure 67. India Plasma Fractionation and Blood Product Sales and Growth Rate (2020-2025) & (K MT)
Figure 68. India Plasma Fractionation and Blood Product Market Size and Growth Rate (2020-2025) & (M USD)
Figure 69. Southeast Asia Plasma Fractionation and Blood Product Sales and Growth Rate (2020-2025) & (K MT)
Figure 70. Southeast Asia Plasma Fractionation and Blood Product Market Size and Growth Rate (2020-2025) & (M USD)
Figure 71. Asia-Pacific Plasma Fractionation and Blood Product Market Size (M USD) by Type
Figure 72. Asia-Pacific Plasma Fractionation and Blood Product Market Size (M USD) by Application
Figure 73. South America Market Snapshot
Figure 74. South America Plasma Fractionation and Blood Product Sales and Growth Rate (2020-2033) & (K MT)
Figure 75. South America Plasma Fractionation and Blood Product Market Size and Growth Rate (2020-2033) & (M USD)
Figure 76. South America Plasma Fractionation and Blood Product Market Size (M USD) by Country
Figure 77. Brazil Plasma Fractionation and Blood Product Sales and Growth Rate (2020-2033) & (K MT)
Figure 78. Brazil Plasma Fractionation and Blood Product Market Size and Growth Rate (2020-2033) & (M USD)
Figure 79. Argentina Plasma Fractionation and Blood Product Sales and Growth Rate (2020-2033) & (K MT)
Figure 80. Argentina Plasma Fractionation and Blood Product Market Size and Growth Rate (2020-2033) & (M USD)
Figure 81. Columbia Plasma Fractionation and Blood Product Sales and Growth Rate (2020-2033) & (K MT)
Figure 82. Columbia Plasma Fractionation and Blood Product Market Size and Growth Rate (2020-2033) & (M USD)
Figure 83. South America Plasma Fractionation and Blood Product Market Size (M USD) by Type
Figure 84. South America Plasma Fractionation and Blood Product Market Size (M USD) by Application
Figure 85. Middle East and Africa Market Snapshot
Figure 86. Middle East and Africa Plasma Fractionation and Blood Product Sales and Growth Rate (2020-2033) & (K MT)
Figure 87. Middle East and Africa Plasma Fractionation and Blood Product Market Size and Growth Rate (2020-2033) & (M USD)
Figure 88. Middle East and Africa Plasma Fractionation and Blood Product Market Size (M USD) by Country
Figure 89. Saudi Arabia Plasma Fractionation and Blood Product Sales and Growth Rate (2020-2033) & (K MT)
Figure 90. Saudi Arabia Plasma Fractionation and Blood Product Market Size and Growth Rate (2020-2033) & (M USD)
Figure 91. UAE Plasma Fractionation and Blood Product Sales and Growth Rate (2020-2033) & (K MT)
Figure 92. UAE Plasma Fractionation and Blood Product Market Size and Growth Rate (2020-2033) & (M USD)
Figure 93. Egypt Plasma Fractionation and Blood Product Sales and Growth Rate (2020-2033) & (K MT)
Figure 94. Egypt Plasma Fractionation and Blood Product Market Size and Growth Rate (2020-2033) & (M USD)
Figure 95. Nigeria Plasma Fractionation and Blood Product Sales and Growth Rate (2020-2033) & (K MT)
Figure 96. Nigeria Plasma Fractionation and Blood Product Market Size and Growth Rate (2020-2033) & (M USD)
Figure 97. South Africa Plasma Fractionation and Blood Product Sales and Growth Rate (2020-2033) & (K MT)
Figure 98. South Africa Plasma Fractionation and Blood Product Market Size and Growth Rate (2020-2033) & (M USD)
Figure 99. Middle East and Africa Plasma Fractionation and Blood Product Market Size (M USD) by Type
Figure 100. Middle East and Africa Plasma Fractionation and Blood Product Market Size (M USD) by Application
Figure 101. Global Plasma Fractionation and Blood Product Production Market Share by Region (2020-2025)
Figure 102. North America Plasma Fractionation and Blood Product Production (K MT) Growth Rate (2020-2025)
Figure 103. Europe Plasma Fractionation and Blood Product Production (K MT) Growth Rate (2020-2025)
Figure 104. Japan Plasma Fractionation and Blood Product Production (K MT) Growth Rate (2020-2025)
Figure 105. China Plasma Fractionation and Blood Product Production (K MT) Growth Rate (2020-2025)
Figure 106. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 107. Global Plasma Fractionation and Blood Product Market Size by Type (M USD)
Figure 108. Sales Market Share of Plasma Fractionation and Blood Product by Type (2020-2033)
Figure 109. Sales Market Share of Plasma Fractionation and Blood Product by Type in 2024
Figure 110. Market Size Share of Plasma Fractionation and Blood Product by Type (2020-2033)
Figure 111. Market Size Share of Plasma Fractionation and Blood Product by Type in 2024
Figure 112. Global Plasma Fractionation and Blood Product Price (USD/MT) by Type (2020-2033)
Figure 113. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 114. Global Plasma Fractionation and Blood Product Market Size by Application(M USD)
Figure 115. Global Plasma Fractionation and Blood Product Market Share by Application
Figure 116. Global Plasma Fractionation and Blood Product Sales Market Share by Application (2020-2033)
Figure 117. Global Plasma Fractionation and Blood Product Sales Market Share by Application in 2024
Figure 118. Global Plasma Fractionation and Blood Product Market Share by Application (2020-2033)
Figure 119. Global Plasma Fractionation and Blood Product Market Share by Application in 2024
Figure 120. Global Plasma Fractionation and Blood Product Sales Growth Rate by Application (2020-2033)